Top Markets
#1 Nesa Nesa +833.90%
#2 Merlin's Seal BTC Merlin's Seal BTC +46.02%
#3 EXOD EXOD +22.78%
#4 Fartcoin Fartcoin +11.24%
#5 Venom Venom +11.13%
#6 Cash Cat Cash Cat +9.69%
#7 Stacks Stacks +9.38%
#8 Pons Pons +9.23%
#9 PondCoin PondCoin +9.02%
#10 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +8.74%
Coin of the day
Nesa Nesa
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Rang in aandelen #3185
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Aandeelprijs
$10.35
Marktkapitalisatie
$6.19B
Verandering (1 dag)
3.79%
Verandering (1 jaar)
4.34%
Land
CN
Handel Gan & Lee Pharmaceuticals. (603087)

Categorie

Healthcare
Winst voor Gan & Lee Pharmaceuticals. (603087)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Gan & Lee Pharmaceuticals. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Gan & Lee Pharmaceuticals. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
$3.81B -
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
$4.11B -
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
- -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
$1.59B -
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
- -
CH